Jacob Eifer Møller

Medicine & Life Sciences

1. Cardiogenic Shock 100%
2. Myocardial Infarction 69%
3. Out-of-Hospital Cardiac Arrest 68%
4. Heart Failure 51%
5. Heart Arrest 31%
6. empagliflozin 30%
7. Mortality 29%
8. Hemodynamics 24%
9. ST Elevation Myocardial Infarction 20%
10. Left Ventricular Function 19%
11. Heart-Assist Devices 19%
12. Coma 19%
13. Stroke Volume 18%
14. Induced Hypothermia 18%
15. Randomized Controlled Trials 17%
16. Survivors 17%
17. Exercise 17%
18. Placebos 16%
19. Calcification of Aortic Valve 15%
20. Biomarkers 14%
21. Percutaneous Coronary Intervention 13%
22. Echocardiography 12%
23. Aortic Valve Stenosis 12%
24. Cohort Studies 11%
25. Heart Valves 11%
26. Thoracic Surgery 11%
27. Cardiac Output 10%
28. Confidence Intervals 10%
29. Blood Pressure 9%
30. Left Atrial Function 9%
31. Mitral Valve 9%
32. Resuscitation 9%
33. Intensive Care Units 9%
34. Equipment and Supplies 9%
35. Pulmonary Wedge Pressure 8%
36. Population 8%
37. Cardiac Catheterization 8%
38. Therapeutics 8%
39. Guidelines 7%
40. Aortic Valve 7%
41. Heart Atria 7%
42. Swine 7%
43. Pressure 7%
44. Sodium-Glucose Transport Proteins 6%
45. Lactic Acid 6%
46. Hypothermia 6%
47. Mitral Valve Insufficiency 6%
48. Lipocalin-2 6%
49. Brain Natriuretic Peptide 6%
50. Registries 6%